Alzheimer's disease: the lipid connection

Hartmann, Tobias; Kuchenbecker, Johannna; Grimm, Marcus O. W.

doi:10.1111/j.1471-4159.2007.04715.x

Cited by 175

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Alzheimer's disease: the lipid connection

Hartmann, Tobias, Kuchenbecker, Johannna, Grimm, Marcus O. W.·2007·Journal of Neurochemistry

DOI 10.1111/j.1471-4159.2007.04715.x

Open this paper in CoChat — free account

Abstract

Alzheimer’s disease is the most common neurodegenerative disorder. This short review summarizes the current knowledge about the role of lipids, especially cholesterol, sphingolipids, plasmalogens, and polyunsaturated fatty acids in Alzheimer’s disease etiology, pathogenesis, risk‐factors, prevention, treatment, and the function of the amyloid precursor protein and the amyloid peptides in lipid homeostasis.

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2007.04715.x

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Outside lipid rafts, APP is processed at the plasma membrane by α-secretase and -secretases producing sAPP-α via the non-amyloidogenic pathway.
“Outside of lipid rafts, APP is processed at the PM by α-secretase and -secretases producing sAPP-α (non-amyloidogenic pathway) [38–40].”
From Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 Lipidation (2023) · cites this paper as [38]

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 1×
“BACE1 is mainly expressed in neurons and the majority of BACE molecules are located in the Golgi apparatus and endosomes (Vassar et al., 1999).”
Background
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149
Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)
Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774
Dietary fat intake and the risk of incident dementia in the Rotterdam study
Kalmijn, S., Launer, L. J., Ott, A., Witteman, J. C. M., Hofman, A., & Breteler, M. M. B. (1997) · Annals of Neurology · doi:10.1002/ana.410420514 · Cited by 895 · cited 1×
“Numerous epidemiological studies indicate an inverse correlation between DHA intake and AD incidence (Barberger-Gateau et al., 2002; Kalmijn et al., 1997; Morris et al., 2003).”
Background
ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study: A Randomized Double-blind Trial
Freund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxén-Irving, G., Garlind, A., Vedin, I., Vessby, B., Wahlund, L.-O., & Palmblad, J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1402 · Cited by 751
Control of Peripheral Nerve Myelination by the ß-Secretase BACE1
Willem, M., Garratt, A. N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., DeStrooper, B., Saftig, P., Birchmeier, C., & Haass, C. (2006) · Science · doi:10.1126/science.1132341 · Cited by 703
Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis
Han, X., M. Holtzman, D., W. McKeel, D., Kelley, J., & Morris, J. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00997.x · Cited by 626
γ-Secretase, notch, Aβ and alzheimer's disease: Where do the presenilins fit in?
Sisodia, S. S., & St George-Hyslop, P. H. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn785 · Cited by 512
Cholesterol homeostasis and function in neurons of the central nervous system
Pfrieger, F. W. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3018-7 · Cited by 453
Lipid Alterations in the Earliest Clinically Recognizable Stage of Alzheimers Disease: Implication of the Role of Lipids in the Pathogenesis of Alzheimers Disease
Han, X. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772786 · Cited by 183

Flagged first, then by citations

Research works printed but not linked: 122

Albers D. S., 2000, Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease, J. Neural Transm. Suppl., 59, 133
10.1002/jnr.10737 · DOI
10.1046/j.1471-4159.1997.69041746.x · DOI
10.1136/bmj.325.7370.932 · DOI
Bassett C. N., 2003, Lipoproteins and lipid peroxidation in Alzheimer’s disease, J. Nutr. Health Aging, 7, 24
10.1046/j.1471-4159.2002.01228.x · DOI
10.1001/archneur.1991.00530220048018 · DOI
10.2105/AJPH.88.9.1337 · DOI
10.1016/S1097-2765(02)00591-9 · DOI · Paper page
10.1016/S0092-8674(00)80675-3 · DOI · Paper page
10.1073/pnas.90.19.9195 · DOI
10.1074/jbc.273.43.27765 · DOI
10.1038/85064 · DOI
10.1016/S0197-0186(00)00128-5 · DOI · Paper page
Cheng H., 2003, Specificity and potential mechanism of sulfatide deficiency in Alzheimer’s disease: an electrospray ionization mass spectrometric study, Cell. Mol. Biol. (Noisy-le-grand), 49, 809
10.1126/science.8346443 · DOI · Paper page
10.1073/pnas.0305799101 · DOI · Paper page
10.1006/neur.1996.0060 · DOI
10.1016/S0896-6273(03)00205-8 · DOI · Paper page
10.1016/0952-3278(95)90123-X · DOI
10.1194/jlr.R400004-JLR200 · DOI · Paper page
10.1016/S0896-6273(00)80232-9 · DOI
10.1016/j.neurobiolaging.2004.08.002 · DOI
10.1083/jcb.200207113 · DOI · Paper page
10.1177/107385840100700308 · DOI
10.1007/978-1-4419-9072-3_45 · DOI
10.1016/0165-0173(95)00008-9 · DOI
10.1073/pnas.160115697 · DOI · Paper page
10.1073/pnas.081620098 · DOI · Paper page
10.1016/S0140-6736(05)67889-0 · DOI
10.1074/jbc.M211485200 · DOI · Paper page
10.1021/bi0494976 · DOI
10.1016/S1534-5807(02)00189-2 · DOI
10.1186/gb-2004-5-11-248 · DOI
10.1046/j.1471-4159.1996.67051882.x · DOI
10.1016/0006-8993(95)00931-F · DOI
10.1046/j.1471-4159.1998.70062533.x · DOI
10.1073/pnas.022523499 · DOI
10.1038/ncb1313 · DOI
10.1038/ncb0702-e164b · DOI
10.1111/j.1600-0404.2006.00682.x · DOI
10.1074/jbc.M210047200 · DOI
10.1097/00005072-199907000-00008 · DOI
10.1046/j.1471-4159.2001.00332.x · DOI
10.1126/science.1566067 · DOI · Paper page
10.1093/hmg/11.21.2615 · DOI
10.1038/nm0997-1016 · DOI
10.1046/j.1471-4159.2002.00905.x · DOI
10.1001/archneur.61.3.333 · DOI
10.1074/jbc.M004175200 · DOI · Paper page
10.1016/j.bbrc.2006.08.077 · DOI
10.1016/S0163-7827(97)00011-8 · DOI
10.1016/S0140-6736(00)03155-X · DOI
10.1159/000095267 · DOI
10.1023/B:GLYC.0000016743.25495.45 · DOI
10.1007/s10719-006-6671-x · DOI
10.1136/bmj.322.7300.1447 · DOI · Paper page
Koike H., 1999, Membrane‐anchored metalloprotease MDC9 has an alpha‐secretase activity responsible for processing the amyloid precursor protein, Biochem. J., 2, 371, 10.1042/bj3430371 · DOI
10.1016/S0021-9258(17)32449-3 · DOI · Paper page
Kracun I., 1990, Brain gangliosides in Alzheimer’s disease, J. Hirnforsch, 31, 789
10.1073/pnas.96.7.3922 · DOI · Paper page
10.1074/jbc.M507217200 · DOI
LeBlanc A. C., 1998, Protein kinase C activation increases release of secreted amyloid precursor protein without decreasing Abeta production in human primary neuron cultures, J. Neurosci., 18, 2907, 10.1523/JNEUROSCI.18-08-02907.1998 · DOI
10.1074/jbc.M208164200 · DOI
10.1074/jbc.M303861200 · DOI · Paper page
10.1523/JNEUROSCI.4225-04.2005 · DOI
10.1038/85059 · DOI · Paper page
10.1111/j.1750-3639.1999.tb00215.x · DOI
10.3109/07853898909149190 · DOI
10.1111/j.1471-4159.2006.03989.x · DOI
10.1523/JNEUROSCI.23-01-00029.2003 · DOI
10.1046/j.1471-4159.1999.0730532.x · DOI
10.1073/pnas.95.21.12683 · DOI
Michal G, 1999, Biochemical Pathways
10.1046/j.1471-4159.1999.0720443.x · DOI
10.1016/S0002-9440(10)62347-4 · DOI
10.1001/archneur.60.7.940 · DOI · Paper page
10.1038/385733a0 · DOI · Paper page
10.1007/s00702-003-0007-9 · DOI
10.1016/S0092-8674(01)00215-X · DOI
10.1152/ajpcell.00636.2004 · DOI
10.1021/bi0509494 · DOI
10.1016/j.nbd.2006.04.013 · DOI
10.1097/00001756-200006260-00030 · DOI
10.1016/0197-4580(95)02017-9 · DOI
10.1016/0306-4522(93)90456-P · DOI
10.1023/A:1022457605436 · DOI
10.1038/ncb1001-905 · DOI · Paper page
10.1074/jbc.272.39.24536 · DOI
10.1006/nbdi.2001.0422 · DOI
10.1093/hmg/10.12.1317 · DOI · Paper page
10.1001/archneur.59.2.223 · DOI
10.1146/annurev.neuro.26.041002.131334 · DOI
10.1152/physrev.2001.81.2.741 · DOI · Paper page
10.1016/S0197-4580(01)00327-X · DOI
10.1097/00001756-200203250-00019 · DOI · Paper page
10.1073/pnas.95.11.6460 · DOI
10.1002/ana.10292 · DOI
10.1002/neu.1064 · DOI
10.1016/S0076-6879(00)12921-0 · DOI
10.1007/BF02536067 · DOI · Paper page
10.1001/archneur.62.5.753 · DOI · Paper page
10.1194/jlr.R600009-JLR200 · DOI
10.1074/jbc.C200469200 · DOI
10.1046/j.1471-4159.1994.63051802.x · DOI
10.1074/jbc.M414525200 · DOI · Paper page
10.2174/138955706777435643 · DOI
10.1016/S0896-6273(00)80291-3 · DOI
10.1079/BJN2002804 · DOI
10.1385/JMN:17:2:157 · DOI
10.1016/S0962-8924(00)01830-4 · DOI
10.1001/archneur.56.5.587 · DOI
10.1016/0005-2760(94)90262-3 · DOI
10.1006/nbdi.2001.0470 · DOI · Paper page
10.1016/S0009-3084(97)00089-3 · DOI
10.1007/BF00992508 · DOI
10.1128/MCB.22.5.1537-1544.2002 · DOI
10.1083/jcb.132.4.717 · DOI
10.1001/archneur.57.10.1439 · DOI
10.1016/S0197-4580(02)00018-0 · DOI
10.1111/j.1750-3639.1991.tb00668.x · DOI
10.1038/sj.mp.4001509 · DOI

Sorted by citations

Functions of plasmalogen lipids in health and disease
Braverman, N. E., & Moser, A. B. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.05.008 · Cited by 1,082
Linking lipids to Alzheimer's disease: cholesterol and beyond
Di Paolo, G., & Kim, T.-W. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3012 · Cited by 972
Lipid Oxidation and Peroxidation in CNS Health and Disease: From Molecular Mechanisms to Therapeutic Opportunities
Adibhatla, R. M., & Hatcher, J. F. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2668 · Cited by 480
The chemistry of Alzheimer’s disease
Rauk, A. (2009) · Chemical Society Reviews · doi:10.1039/b807980n · Cited by 417
Brain lipidomics: From functional landscape to clinical significance
Yoon, J. H., Seo, Y., Jo, Y. S., Lee, S., Cho, E., Cazenave-Gassiot, A., Shin, Y.-S., Moon, M. H., An, H. J., Wenk, M. R., et al. (2022) · Science Advances · doi:10.1126/sciadv.adc9317 · Cited by 324
Aging and Alzheimer's disease: comparison and associations from molecular to system level
Xia, X., Jiang, Q., McDermott, J., & Han, J. J. (2018) · Aging Cell · doi:10.1111/acel.12802 · Cited by 301
Plasmalogens and Alzheimer’s disease: A review
Su, X. Q., Wang, J., & Sinclair, A. J. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1044-1 · Cited by 172
Targeting Synaptic Dysfunction in Alzheimer’s Disease by Administering a Specific Nutrient Combination
van Wijk, N., Broersen, L. M., de Wilde, M. C., Hageman, R. J. J., Groenendijk, M., Sijben, J. W. C., & Kamphuis, P. J. G. H. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130998 · Cited by 128
Plasmalogens rescue neuronal cell death through an activation of AKT and ERK survival signaling
Hossain, M. S., Ifuku, M., Take, S., Kawamura, J., Miake, K., & Katafuchi, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083508 · Cited by 116
Inhibiting ACAT1/SOAT1 in microglia stimulates autophagy-mediated lysosomal proteolysis and increases Aβ1-42 clearance
Shibuya, Y., Chang, C. C. Y., Huang, L.-H., Bryleva, E. Y., & Chang, T.-Y. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2567-14.2014 · Cited by 108
“Lipid metabolism is closely associated with AD at several stages (Hartmann et al., 2007).”
Background
Capillary cerebral amyloid angiopathy identifies a distinct APOE ε4-associated subtype of sporadic Alzheimer’s disease
Thal, D. R., Papassotiropoulos, A., Saido, T. C., Griffin, W. S. T., Mrak, R. E., Kölsch, H., Tredici, K. D., Attems, J., & Ghebremedhin, E. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0707-9 · Cited by 103
Impaired Plasmalogens in Patients with Schizophrenia
Kaddurah-Daouk, R., McEvoy, J., Baillie, R., Zhu, H., K. Yao, J., Nimgaonkar, V. L., Buckley, P. F., Keshavan, M. S., Georgiades, A., & Nasrallah, H. A. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.02.019 · Cited by 89
A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeleton
Braverman, N., Zhang, R., Chen, L., Nimmo, G., Scheper, S., Tran, T., Chaudhury, R., Moser, A., & Steinberg, S. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2009.12.005 · Cited by 66
Potential therapeutic target for aging and age-related neurodegenerative diseases: the role of acid sphingomyelinase
Park, M. H., Jin, H. K., & Bae, J.-S. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0399-8 · Cited by 59
Membrane raft domains and remodeling in aging brain
Colin, J., Gregory-Pauron, L., Lanhers, M.-C., Claudepierre, T., Corbier, C., Yen, F. T., Malaplate-Armand, C., & Oster, T. (2016) · Biochimie · doi:10.1016/j.biochi.2016.08.014 · Cited by 55
Nerve growth factor (NGF) and pro‐NGF increase low‐density lipoprotein (LDL) receptors in neuronal cells partly by different mechanisms: role of LDL in neurite outgrowth
Do, H. T., Bruelle, C., Pham, D. D., Jauhiainen, M., Eriksson, O., Korhonen, L. T., & Lindholm, D. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13397 · Cited by 37
Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 Lipidation
Valencia-Olvera, A. C., Balu, D., Faulk, N., Amiridis, A., Wang, Y., Pham, C., Avila-Munoz, E., York, J. M., Thatcher, G. R. J., & LaDu, M. J. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01375-3 · Cited by 22
HOCl-Mediated Glycerophosphocholine and Glycerophosphoethanolamine Generation From Plasmalogens in Phospholipid Mixtures
Leßig, J., & Fuchs, B. (2010) · Lipids · doi:10.1007/s11745-009-3365-8 · Cited by 21

Authors: Hartmann, T., Kuchenbecker, J., & Grimm, M. O. W.
Venue: Journal of Neurochemistry
Publisher: Wiley
Published: 2007-11
Volume: 103
Issue: s1
Pages: 159-170
ISSN: 0022-3042
1471-4159
DOI: 10.1111/j.1471-4159.2007.04715.x
Cited by: 175
References: 11
Language: en
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 5 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Alzheimer's disease: the lipid connection

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Metadata

Record

About these checks